What is LOPJLB’s current signal on PULM?

LOPJLB’s latest quantitative signal on Pulmatrix, Inc. (PULM) is SELL in a BEAR regime. Signals are updated daily.

What market regime is PULM in?

Pulmatrix, Inc. (PULM) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Pulmatrix, Inc. (PULM) do?

Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology. This proprietary platform al…

Where is Pulmatrix, Inc. based / listed?

Pulmatrix, Inc. is based in US, listed on NASDAQ.

Pulmatrix, Inc. (PULM)

Healthcare · Biotechnology · NASDAQ · US

$1.55+3.33%Close

SELLBEAR · day 1

[SCORES & PROFILE]

FUND: 12
VALUE: 8
GROWTH: 39
GARP: 2
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-65.6%

REV YoY-

ROE-109.3%

EPS YoY-

ROA-123.6%

GROSS

NET

[VALUATION]

P/E TTM-1.41

P/E FWD-

SECTOR PE22.66

INDUSTRY PE17.07

P/B2.21

P/FCF-

EV/EBITDA-0.87

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO4.70

ND/EBITDA-

BETA1.92

Pulmatrix, Inc. (PULM)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news